- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05731206
가수분해 단백질 유아용 분유의 저자극성 (HYPO STORY)
우유 알레르기가 확인된 어린이의 가수분해 단백질 포뮬러의 저자극성을 평가하기 위한 연구
Study to demonstrate hypoallergenicity of a hydrolysed protein infant formula in a population of children with confirmed cow's milk allergy.
연구 개요
상태
정황
상세 설명
The study consists of a double-blind, placebo-controlled food challenge, followed by a single arm open challenge.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Rome, 이탈리아
- Pediatric hospital Bambino Gesù
-
수석 연구원:
- Alessandro Fiocchi, Prof
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Infants and children aged up to 3 years.
-
Diagnosed with cow's milk allergy (or re-confirmed), within two months prior to the study (challenge day #1), by:
- Physician-supervised double-blind oral food challenge; or
- Physician-supervised open oral food challenge that elicited objective immediate allergic reactions; or
- Report of convincing allergic reaction to cow's milk or a milk-containing food product, in conjunction with presence of milk-specific serum Immunoglobuline E (IgE) level > 0.7 kilounit per liter (U/L) or by skin prick test (wheal size ≥ 3mm).
-
Willing to switch to a different hypoallergenic formula
-
On elimination diet (commercially available, hypoallergenic infant formula ) and free of clinical symptoms, or with controlled stable symptoms, for at least one week preceding the study (challenge day #1).
-
Expected minimal consumption of 144ml of test product/day during the open challenge.
-
Written informed consent provided by parents/guardians, according to local law.
Exclusion Criteria:
- Infants/children who are more suitable to use AAF as first-line formula, including but not limited to those with high risk of anaphylaxis (prior history of anaphylaxis and currently not using eHF) or severe forms of non-IgE-mediated CMA such as eosinophilic oesophagitis, enteropathies, or Food Protein-Induced Enterocolitis Syndrome (FPIES).
- Diagnosis or known allergy to any of the ingredients in the test product.
- Congenital anomalies which will interfere with oral feeding or gastrointestinal tract, other chronic diseases (including but not limited to cardiovascular disease, malignancy, hepatic disease, renal disease, haematological disease, neurological disease, immunological and endocrine disease), major gastrointestinal disease/abnormalities, or any other medical condition that could interfere with the identification of allergic reactions.
- (Twin / triplet) sibling of an infant/child already participating in the study.
- Investigator's uncertainty about the willingness or ability of the subject and his/her parents to comply with the protocol requirements.
- Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.
- Employees and/or children/family members or relatives of employees of Nutricia Research or the participating study sites.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: hydrolized protein formula
hydrolysed protein formula |
Hydrolyzed protein infant formula |
|
위약 비교기: Control formula
commercially available hypoallergenic infant formula |
commercially available hypoallergenic infant formula |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Hypoallergenicity
기간: 25-35 days
|
The percentage of children tolerating the formula tested by double-blind, placebo-controlled food challenge and a subsequent open challenge. |
25-35 days
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Relevant parameters routinely collected in the clinic
기간: 25-35 days
|
e.g serum IgE results |
25-35 days
|
|
Incidence, seriousness, severity and relatedness of Adverse Events
기간: 25-35 days
|
Safety and tolerance parameters |
25-35 days
|
|
Demographics characteristics
기간: at baseline
|
Demographics characteristics |
at baseline
|
|
Relevant parameters routinely collected in the clinic
기간: 25-35 days
|
e.g. skin prick test results |
25-35 days
|
|
Birth length
기간: at baseline
|
cm |
at baseline
|
|
Birth weight
기간: at baseline
|
g |
at baseline
|
|
anthropometrics
기간: at baseline
|
e.g. weight and lenght |
at baseline
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .